Global Mirvetuximab Soravtansine Supply, Demand and Key Producers, 2026-2032
The global Mirvetuximab Soravtansine market size is expected to reach $ 2621 million by 2032, rising at a market growth of 15.9% CAGR during the forecast period (2026-2032).
Mirvetuximab Soravtansine is an antibody-drug conjugate (ADC) targeting folate receptor ? (FR?). It is covalently formed by conjugating a humanized anti-FR? monoclonal antibody, a cleavable linker, and the microtubule inhibitor DM4. The drug can specifically recognize and bind to highly expressed FR? on the surface of tumor cells, release cytotoxic payloads after endocytosis into cells, and precisely kill tumor cells. It is mainly used for the treatment of malignant tumors such as FR?-positive recurrent ovarian cancer. Featuring high targeting ability and strong anti-tumor activity, it provides an important targeted therapeutic option for patients with advanced ovarian cancer.In 2025, global Mirvetuximab Soravtansine production reached approximately 105,000–110,000 vials.
As a globally pioneering and the only approved FR?-targeted ADC drug, Mirvetuximab Soravtansine has established significant clinical and market advantages in the field of platinum-resistant ovarian cancer. Its core value lies in the high efficacy and low toxicity profile brought by its precise targeting mechanism, which effectively addresses the long-unmet clinical needs. The global market is mainly led by the United States, and with successive approvals and commercialization in major markets such as the European Union and China, the product has shown a trend of rapid growth. Supported by priority recommendations in authoritative guidelines, it has further driven continuous improvements in physician prescriptions and patient penetration. In China, the commercialization is led by Huadong Medicine, which has achieved early market access and rapid nationwide coverage through favorable innovative drug policies. The advantages of local channels and academic promotion are gradually unlocking market potential. Looking ahead, its market growth will rely on the continuous penetration of ovarian cancer indications on the one hand, and the potential clinical expansion into other FR?-highly-expressing tumors on the other. Meanwhile, it faces multiple constraints including limited accessibility due to high pricing, the progress of medical insurance coverage, and the development of competing products targeting the same target in the future. Overall, the market is expected to grow steadily while accompanied by uncertainties from competition and policy changes.
This report studies the global Mirvetuximab Soravtansine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mirvetuximab Soravtansine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mirvetuximab Soravtansine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mirvetuximab Soravtansine total production and demand, 2021-2032, (Units)
Global Mirvetuximab Soravtansine total production value, 2021-2032, (USD Million)
Global Mirvetuximab Soravtansine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Mirvetuximab Soravtansine consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Mirvetuximab Soravtansine domestic production, consumption, key domestic manufacturers and share
Global Mirvetuximab Soravtansine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Mirvetuximab Soravtansine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Mirvetuximab Soravtansine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Mirvetuximab Soravtansine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Hangzhou Sino-American East China Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Mirvetuximab Soravtansine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mirvetuximab Soravtansine Market, By Region:
1. How big is the global Mirvetuximab Soravtansine market?
2. What is the demand of the global Mirvetuximab Soravtansine market?
3. What is the year over year growth of the global Mirvetuximab Soravtansine market?
4. What is the production and production value of the global Mirvetuximab Soravtansine market?
5. Who are the key producers in the global Mirvetuximab Soravtansine market?
6. What are the growth factors driving the market demand?
Mirvetuximab Soravtansine is an antibody-drug conjugate (ADC) targeting folate receptor ? (FR?). It is covalently formed by conjugating a humanized anti-FR? monoclonal antibody, a cleavable linker, and the microtubule inhibitor DM4. The drug can specifically recognize and bind to highly expressed FR? on the surface of tumor cells, release cytotoxic payloads after endocytosis into cells, and precisely kill tumor cells. It is mainly used for the treatment of malignant tumors such as FR?-positive recurrent ovarian cancer. Featuring high targeting ability and strong anti-tumor activity, it provides an important targeted therapeutic option for patients with advanced ovarian cancer.In 2025, global Mirvetuximab Soravtansine production reached approximately 105,000–110,000 vials.
As a globally pioneering and the only approved FR?-targeted ADC drug, Mirvetuximab Soravtansine has established significant clinical and market advantages in the field of platinum-resistant ovarian cancer. Its core value lies in the high efficacy and low toxicity profile brought by its precise targeting mechanism, which effectively addresses the long-unmet clinical needs. The global market is mainly led by the United States, and with successive approvals and commercialization in major markets such as the European Union and China, the product has shown a trend of rapid growth. Supported by priority recommendations in authoritative guidelines, it has further driven continuous improvements in physician prescriptions and patient penetration. In China, the commercialization is led by Huadong Medicine, which has achieved early market access and rapid nationwide coverage through favorable innovative drug policies. The advantages of local channels and academic promotion are gradually unlocking market potential. Looking ahead, its market growth will rely on the continuous penetration of ovarian cancer indications on the one hand, and the potential clinical expansion into other FR?-highly-expressing tumors on the other. Meanwhile, it faces multiple constraints including limited accessibility due to high pricing, the progress of medical insurance coverage, and the development of competing products targeting the same target in the future. Overall, the market is expected to grow steadily while accompanied by uncertainties from competition and policy changes.
This report studies the global Mirvetuximab Soravtansine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mirvetuximab Soravtansine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mirvetuximab Soravtansine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mirvetuximab Soravtansine total production and demand, 2021-2032, (Units)
Global Mirvetuximab Soravtansine total production value, 2021-2032, (USD Million)
Global Mirvetuximab Soravtansine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Mirvetuximab Soravtansine consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Mirvetuximab Soravtansine domestic production, consumption, key domestic manufacturers and share
Global Mirvetuximab Soravtansine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Mirvetuximab Soravtansine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Mirvetuximab Soravtansine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Mirvetuximab Soravtansine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Hangzhou Sino-American East China Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Mirvetuximab Soravtansine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mirvetuximab Soravtansine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Lyophilized Powder for Injection
- Injectable Solution
- Mirvetuximab Soravtansine In Combination With Bevacizumab
- Mirvetuximab Soravtansine In Combination With Carboplatin
- Hospital
- Retail
- Online
- FR?-Positive Recurrent Ovarian Cancer
- Platinum-Resistant Epithelial Ovarian Cancer
- FR?-Highly Expressed Advanced Solid Tumors
- Others
- AbbVie
- Hangzhou Sino-American East China Pharmaceutical
1. How big is the global Mirvetuximab Soravtansine market?
2. What is the demand of the global Mirvetuximab Soravtansine market?
3. What is the year over year growth of the global Mirvetuximab Soravtansine market?
4. What is the production and production value of the global Mirvetuximab Soravtansine market?
5. Who are the key producers in the global Mirvetuximab Soravtansine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Mirvetuximab Soravtansine Introduction
1.2 World Mirvetuximab Soravtansine Supply & Forecast
1.2.1 World Mirvetuximab Soravtansine Production Value (2021 & 2025 & 2032)
1.2.2 World Mirvetuximab Soravtansine Production (2021-2032)
1.2.3 World Mirvetuximab Soravtansine Pricing Trends (2021-2032)
1.3 World Mirvetuximab Soravtansine Production by Region (Based on Production Site)
1.3.1 World Mirvetuximab Soravtansine Production Value by Region (2021-2032)
1.3.2 World Mirvetuximab Soravtansine Production by Region (2021-2032)
1.3.3 World Mirvetuximab Soravtansine Average Price by Region (2021-2032)
1.3.4 North America Mirvetuximab Soravtansine Production (2021-2032)
1.3.5 Europe Mirvetuximab Soravtansine Production (2021-2032)
1.3.6 China Mirvetuximab Soravtansine Production (2021-2032)
1.3.7 Japan Mirvetuximab Soravtansine Production (2021-2032)
1.3.8 India Mirvetuximab Soravtansine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mirvetuximab Soravtansine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Mirvetuximab Soravtansine Major Market Trends
2 DEMAND SUMMARY
2.1 World Mirvetuximab Soravtansine Demand (2021-2032)
2.2 World Mirvetuximab Soravtansine Consumption by Region
2.2.1 World Mirvetuximab Soravtansine Consumption by Region (2021-2026)
2.2.2 World Mirvetuximab Soravtansine Consumption Forecast by Region (2027-2032)
2.3 United States Mirvetuximab Soravtansine Consumption (2021-2032)
2.4 China Mirvetuximab Soravtansine Consumption (2021-2032)
2.5 Europe Mirvetuximab Soravtansine Consumption (2021-2032)
2.6 Japan Mirvetuximab Soravtansine Consumption (2021-2032)
2.7 South Korea Mirvetuximab Soravtansine Consumption (2021-2032)
2.8 ASEAN Mirvetuximab Soravtansine Consumption (2021-2032)
2.9 India Mirvetuximab Soravtansine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Mirvetuximab Soravtansine Production Value by Manufacturer (2021-2026)
3.2 World Mirvetuximab Soravtansine Production by Manufacturer (2021-2026)
3.3 World Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026)
3.4 Mirvetuximab Soravtansine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Mirvetuximab Soravtansine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Mirvetuximab Soravtansine in 2025
3.5.3 Global Concentration Ratios (CR8) for Mirvetuximab Soravtansine in 2025
3.6 Mirvetuximab Soravtansine Market: Overall Company Footprint Analysis
3.6.1 Mirvetuximab Soravtansine Market: Region Footprint
3.6.2 Mirvetuximab Soravtansine Market: Company Product Type Footprint
3.6.3 Mirvetuximab Soravtansine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Mirvetuximab Soravtansine Production Value Comparison
4.1.1 United States VS China: Mirvetuximab Soravtansine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Mirvetuximab Soravtansine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Mirvetuximab Soravtansine Production Comparison
4.2.1 United States VS China: Mirvetuximab Soravtansine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mirvetuximab Soravtansine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Mirvetuximab Soravtansine Consumption Comparison
4.3.1 United States VS China: Mirvetuximab Soravtansine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Mirvetuximab Soravtansine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Mirvetuximab Soravtansine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Mirvetuximab Soravtansine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Mirvetuximab Soravtansine Production (2021-2026)
4.5 China Based Mirvetuximab Soravtansine Manufacturers and Market Share
4.5.1 China Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Mirvetuximab Soravtansine Production Value (2021-2026)
4.5.3 China Based Manufacturers Mirvetuximab Soravtansine Production (2021-2026)
4.6 Rest of World Based Mirvetuximab Soravtansine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Mirvetuximab Soravtansine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mirvetuximab Soravtansine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Lyophilized Powder for Injection
5.2.2 Injectable Solution
5.3 Market Segment by Type
5.3.1 World Mirvetuximab Soravtansine Production by Type (2021-2032)
5.3.2 World Mirvetuximab Soravtansine Production Value by Type (2021-2032)
5.3.3 World Mirvetuximab Soravtansine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION MEDICATION
6.1 World Mirvetuximab Soravtansine Market Size Overview by Combination Medication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination Medication
6.2.1 Mirvetuximab Soravtansine In Combination With Bevacizumab
6.2.2 Mirvetuximab Soravtansine In Combination With Carboplatin
6.3 Market Segment by Combination Medication
6.3.1 World Mirvetuximab Soravtansine Production by Combination Medication (2021-2032)
6.3.2 World Mirvetuximab Soravtansine Production Value by Combination Medication (2021-2032)
6.3.3 World Mirvetuximab Soravtansine Average Price by Combination Medication (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Mirvetuximab Soravtansine Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Hospital
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channels
7.3.1 World Mirvetuximab Soravtansine Production by Sales Channels (2021-2032)
7.3.2 World Mirvetuximab Soravtansine Production Value by Sales Channels (2021-2032)
7.3.3 World Mirvetuximab Soravtansine Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Mirvetuximab Soravtansine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 FR?-Positive Recurrent Ovarian Cancer
8.2.2 Platinum-Resistant Epithelial Ovarian Cancer
8.2.3 FR?-Highly Expressed Advanced Solid Tumors
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Mirvetuximab Soravtansine Production by Application (2021-2032)
8.3.2 World Mirvetuximab Soravtansine Production Value by Application (2021-2032)
8.3.3 World Mirvetuximab Soravtansine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 AbbVie
9.1.1 AbbVie Details
9.1.2 AbbVie Major Business
9.1.3 AbbVie Mirvetuximab Soravtansine Product and Services
9.1.4 AbbVie Mirvetuximab Soravtansine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 AbbVie Recent Developments/Updates
9.1.6 AbbVie Competitive Strengths & Weaknesses
9.2 Hangzhou Sino-American East China Pharmaceutical
9.2.1 Hangzhou Sino-American East China Pharmaceutical Details
9.2.2 Hangzhou Sino-American East China Pharmaceutical Major Business
9.2.3 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
9.2.4 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
9.2.6 Hangzhou Sino-American East China Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Mirvetuximab Soravtansine Industry Chain
10.2 Mirvetuximab Soravtansine Upstream Analysis
10.2.1 Mirvetuximab Soravtansine Core Raw Materials
10.2.2 Main Manufacturers of Mirvetuximab Soravtansine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Mirvetuximab Soravtansine Production Mode
10.6 Mirvetuximab Soravtansine Procurement Model
10.7 Mirvetuximab Soravtansine Industry Sales Model and Sales Channels
10.7.1 Mirvetuximab Soravtansine Sales Model
10.7.2 Mirvetuximab Soravtansine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Mirvetuximab Soravtansine Introduction
1.2 World Mirvetuximab Soravtansine Supply & Forecast
1.2.1 World Mirvetuximab Soravtansine Production Value (2021 & 2025 & 2032)
1.2.2 World Mirvetuximab Soravtansine Production (2021-2032)
1.2.3 World Mirvetuximab Soravtansine Pricing Trends (2021-2032)
1.3 World Mirvetuximab Soravtansine Production by Region (Based on Production Site)
1.3.1 World Mirvetuximab Soravtansine Production Value by Region (2021-2032)
1.3.2 World Mirvetuximab Soravtansine Production by Region (2021-2032)
1.3.3 World Mirvetuximab Soravtansine Average Price by Region (2021-2032)
1.3.4 North America Mirvetuximab Soravtansine Production (2021-2032)
1.3.5 Europe Mirvetuximab Soravtansine Production (2021-2032)
1.3.6 China Mirvetuximab Soravtansine Production (2021-2032)
1.3.7 Japan Mirvetuximab Soravtansine Production (2021-2032)
1.3.8 India Mirvetuximab Soravtansine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mirvetuximab Soravtansine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Mirvetuximab Soravtansine Major Market Trends
2 DEMAND SUMMARY
2.1 World Mirvetuximab Soravtansine Demand (2021-2032)
2.2 World Mirvetuximab Soravtansine Consumption by Region
2.2.1 World Mirvetuximab Soravtansine Consumption by Region (2021-2026)
2.2.2 World Mirvetuximab Soravtansine Consumption Forecast by Region (2027-2032)
2.3 United States Mirvetuximab Soravtansine Consumption (2021-2032)
2.4 China Mirvetuximab Soravtansine Consumption (2021-2032)
2.5 Europe Mirvetuximab Soravtansine Consumption (2021-2032)
2.6 Japan Mirvetuximab Soravtansine Consumption (2021-2032)
2.7 South Korea Mirvetuximab Soravtansine Consumption (2021-2032)
2.8 ASEAN Mirvetuximab Soravtansine Consumption (2021-2032)
2.9 India Mirvetuximab Soravtansine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Mirvetuximab Soravtansine Production Value by Manufacturer (2021-2026)
3.2 World Mirvetuximab Soravtansine Production by Manufacturer (2021-2026)
3.3 World Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026)
3.4 Mirvetuximab Soravtansine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Mirvetuximab Soravtansine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Mirvetuximab Soravtansine in 2025
3.5.3 Global Concentration Ratios (CR8) for Mirvetuximab Soravtansine in 2025
3.6 Mirvetuximab Soravtansine Market: Overall Company Footprint Analysis
3.6.1 Mirvetuximab Soravtansine Market: Region Footprint
3.6.2 Mirvetuximab Soravtansine Market: Company Product Type Footprint
3.6.3 Mirvetuximab Soravtansine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Mirvetuximab Soravtansine Production Value Comparison
4.1.1 United States VS China: Mirvetuximab Soravtansine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Mirvetuximab Soravtansine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Mirvetuximab Soravtansine Production Comparison
4.2.1 United States VS China: Mirvetuximab Soravtansine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mirvetuximab Soravtansine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Mirvetuximab Soravtansine Consumption Comparison
4.3.1 United States VS China: Mirvetuximab Soravtansine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Mirvetuximab Soravtansine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Mirvetuximab Soravtansine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Mirvetuximab Soravtansine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Mirvetuximab Soravtansine Production (2021-2026)
4.5 China Based Mirvetuximab Soravtansine Manufacturers and Market Share
4.5.1 China Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Mirvetuximab Soravtansine Production Value (2021-2026)
4.5.3 China Based Manufacturers Mirvetuximab Soravtansine Production (2021-2026)
4.6 Rest of World Based Mirvetuximab Soravtansine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Mirvetuximab Soravtansine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mirvetuximab Soravtansine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Lyophilized Powder for Injection
5.2.2 Injectable Solution
5.3 Market Segment by Type
5.3.1 World Mirvetuximab Soravtansine Production by Type (2021-2032)
5.3.2 World Mirvetuximab Soravtansine Production Value by Type (2021-2032)
5.3.3 World Mirvetuximab Soravtansine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION MEDICATION
6.1 World Mirvetuximab Soravtansine Market Size Overview by Combination Medication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination Medication
6.2.1 Mirvetuximab Soravtansine In Combination With Bevacizumab
6.2.2 Mirvetuximab Soravtansine In Combination With Carboplatin
6.3 Market Segment by Combination Medication
6.3.1 World Mirvetuximab Soravtansine Production by Combination Medication (2021-2032)
6.3.2 World Mirvetuximab Soravtansine Production Value by Combination Medication (2021-2032)
6.3.3 World Mirvetuximab Soravtansine Average Price by Combination Medication (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Mirvetuximab Soravtansine Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Hospital
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channels
7.3.1 World Mirvetuximab Soravtansine Production by Sales Channels (2021-2032)
7.3.2 World Mirvetuximab Soravtansine Production Value by Sales Channels (2021-2032)
7.3.3 World Mirvetuximab Soravtansine Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Mirvetuximab Soravtansine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 FR?-Positive Recurrent Ovarian Cancer
8.2.2 Platinum-Resistant Epithelial Ovarian Cancer
8.2.3 FR?-Highly Expressed Advanced Solid Tumors
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Mirvetuximab Soravtansine Production by Application (2021-2032)
8.3.2 World Mirvetuximab Soravtansine Production Value by Application (2021-2032)
8.3.3 World Mirvetuximab Soravtansine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 AbbVie
9.1.1 AbbVie Details
9.1.2 AbbVie Major Business
9.1.3 AbbVie Mirvetuximab Soravtansine Product and Services
9.1.4 AbbVie Mirvetuximab Soravtansine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 AbbVie Recent Developments/Updates
9.1.6 AbbVie Competitive Strengths & Weaknesses
9.2 Hangzhou Sino-American East China Pharmaceutical
9.2.1 Hangzhou Sino-American East China Pharmaceutical Details
9.2.2 Hangzhou Sino-American East China Pharmaceutical Major Business
9.2.3 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
9.2.4 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
9.2.6 Hangzhou Sino-American East China Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Mirvetuximab Soravtansine Industry Chain
10.2 Mirvetuximab Soravtansine Upstream Analysis
10.2.1 Mirvetuximab Soravtansine Core Raw Materials
10.2.2 Main Manufacturers of Mirvetuximab Soravtansine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Mirvetuximab Soravtansine Production Mode
10.6 Mirvetuximab Soravtansine Procurement Model
10.7 Mirvetuximab Soravtansine Industry Sales Model and Sales Channels
10.7.1 Mirvetuximab Soravtansine Sales Model
10.7.2 Mirvetuximab Soravtansine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Mirvetuximab Soravtansine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Mirvetuximab Soravtansine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Mirvetuximab Soravtansine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Mirvetuximab Soravtansine Production Value Market Share by Region (2021-2026)
Table 5. World Mirvetuximab Soravtansine Production Value Market Share by Region (2027-2032)
Table 6. World Mirvetuximab Soravtansine Production by Region (2021-2026) & (Units)
Table 7. World Mirvetuximab Soravtansine Production by Region (2027-2032) & (Units)
Table 8. World Mirvetuximab Soravtansine Production Market Share by Region (2021-2026)
Table 9. World Mirvetuximab Soravtansine Production Market Share by Region (2027-2032)
Table 10. World Mirvetuximab Soravtansine Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Mirvetuximab Soravtansine Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Mirvetuximab Soravtansine Major Market Trends
Table 13. World Mirvetuximab Soravtansine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Mirvetuximab Soravtansine Consumption by Region (2021-2026) & (Units)
Table 15. World Mirvetuximab Soravtansine Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Mirvetuximab Soravtansine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Mirvetuximab Soravtansine Producers in 2025
Table 18. World Mirvetuximab Soravtansine Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Mirvetuximab Soravtansine Producers in 2025
Table 20. World Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Mirvetuximab Soravtansine Company Evaluation Quadrant
Table 22. World Mirvetuximab Soravtansine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Mirvetuximab Soravtansine Production Site of Key Manufacturer
Table 24. Mirvetuximab Soravtansine Market: Company Product Type Footprint
Table 25. Mirvetuximab Soravtansine Market: Company Product Application Footprint
Table 26. Mirvetuximab Soravtansine Competitive Factors
Table 27. Mirvetuximab Soravtansine New Entrant and Capacity Expansion Plans
Table 28. Mirvetuximab Soravtansine Mergers & Acquisitions Activity
Table 29. United States VS China Mirvetuximab Soravtansine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Mirvetuximab Soravtansine Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Mirvetuximab Soravtansine Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Mirvetuximab Soravtansine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Mirvetuximab Soravtansine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Mirvetuximab Soravtansine Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Mirvetuximab Soravtansine Production Market Share (2021-2026)
Table 37. China Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Mirvetuximab Soravtansine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Mirvetuximab Soravtansine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Mirvetuximab Soravtansine Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Mirvetuximab Soravtansine Production Market Share (2021-2026)
Table 42. Rest of World Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Market Share (2021-2026)
Table 47. World Mirvetuximab Soravtansine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Mirvetuximab Soravtansine Production by Type (2021-2026) & (Units)
Table 49. World Mirvetuximab Soravtansine Production by Type (2027-2032) & (Units)
Table 50. World Mirvetuximab Soravtansine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Mirvetuximab Soravtansine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Mirvetuximab Soravtansine Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Mirvetuximab Soravtansine Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Mirvetuximab Soravtansine Production Value by Combination Medication, (USD Million), 2021 & 2025 & 2032
Table 55. World Mirvetuximab Soravtansine Production by Combination Medication (2021-2026) & (Units)
Table 56. World Mirvetuximab Soravtansine Production by Combination Medication (2027-2032) & (Units)
Table 57. World Mirvetuximab Soravtansine Production Value by Combination Medication (2021-2026) & (USD Million)
Table 58. World Mirvetuximab Soravtansine Production Value by Combination Medication (2027-2032) & (USD Million)
Table 59. World Mirvetuximab Soravtansine Average Price by Combination Medication (2021-2026) & (US$/Unit)
Table 60. World Mirvetuximab Soravtansine Average Price by Combination Medication (2027-2032) & (US$/Unit)
Table 61. World Mirvetuximab Soravtansine Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Mirvetuximab Soravtansine Production by Sales Channels (2021-2026) & (Units)
Table 63. World Mirvetuximab Soravtansine Production by Sales Channels (2027-2032) & (Units)
Table 64. World Mirvetuximab Soravtansine Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Mirvetuximab Soravtansine Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Mirvetuximab Soravtansine Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Mirvetuximab Soravtansine Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Mirvetuximab Soravtansine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Mirvetuximab Soravtansine Production by Application (2021-2026) & (Units)
Table 70. World Mirvetuximab Soravtansine Production by Application (2027-2032) & (Units)
Table 71. World Mirvetuximab Soravtansine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Mirvetuximab Soravtansine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Mirvetuximab Soravtansine Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Mirvetuximab Soravtansine Average Price by Application (2027-2032) & (US$/Unit)
Table 75. AbbVie Basic Information, Manufacturing Base and Competitors
Table 76. AbbVie Major Business
Table 77. AbbVie Mirvetuximab Soravtansine Product and Services
Table 78. AbbVie Mirvetuximab Soravtansine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. AbbVie Recent Developments/Updates
Table 80. AbbVie Competitive Strengths & Weaknesses
Table 81. Hangzhou Sino-American East China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 82. Hangzhou Sino-American East China Pharmaceutical Major Business
Table 83. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
Table 84. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
Table 86. Hangzhou Sino-American East China Pharmaceutical Competitive Strengths & Weaknesses
Table 87. Global Key Players of Mirvetuximab Soravtansine Upstream (Raw Materials)
Table 88. Global Mirvetuximab Soravtansine Typical Customers
Table 89. Mirvetuximab Soravtansine Typical Distributors
Table 1. World Mirvetuximab Soravtansine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Mirvetuximab Soravtansine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Mirvetuximab Soravtansine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Mirvetuximab Soravtansine Production Value Market Share by Region (2021-2026)
Table 5. World Mirvetuximab Soravtansine Production Value Market Share by Region (2027-2032)
Table 6. World Mirvetuximab Soravtansine Production by Region (2021-2026) & (Units)
Table 7. World Mirvetuximab Soravtansine Production by Region (2027-2032) & (Units)
Table 8. World Mirvetuximab Soravtansine Production Market Share by Region (2021-2026)
Table 9. World Mirvetuximab Soravtansine Production Market Share by Region (2027-2032)
Table 10. World Mirvetuximab Soravtansine Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Mirvetuximab Soravtansine Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Mirvetuximab Soravtansine Major Market Trends
Table 13. World Mirvetuximab Soravtansine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Mirvetuximab Soravtansine Consumption by Region (2021-2026) & (Units)
Table 15. World Mirvetuximab Soravtansine Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Mirvetuximab Soravtansine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Mirvetuximab Soravtansine Producers in 2025
Table 18. World Mirvetuximab Soravtansine Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Mirvetuximab Soravtansine Producers in 2025
Table 20. World Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Mirvetuximab Soravtansine Company Evaluation Quadrant
Table 22. World Mirvetuximab Soravtansine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Mirvetuximab Soravtansine Production Site of Key Manufacturer
Table 24. Mirvetuximab Soravtansine Market: Company Product Type Footprint
Table 25. Mirvetuximab Soravtansine Market: Company Product Application Footprint
Table 26. Mirvetuximab Soravtansine Competitive Factors
Table 27. Mirvetuximab Soravtansine New Entrant and Capacity Expansion Plans
Table 28. Mirvetuximab Soravtansine Mergers & Acquisitions Activity
Table 29. United States VS China Mirvetuximab Soravtansine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Mirvetuximab Soravtansine Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Mirvetuximab Soravtansine Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Mirvetuximab Soravtansine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Mirvetuximab Soravtansine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Mirvetuximab Soravtansine Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Mirvetuximab Soravtansine Production Market Share (2021-2026)
Table 37. China Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Mirvetuximab Soravtansine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Mirvetuximab Soravtansine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Mirvetuximab Soravtansine Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Mirvetuximab Soravtansine Production Market Share (2021-2026)
Table 42. Rest of World Based Mirvetuximab Soravtansine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Market Share (2021-2026)
Table 47. World Mirvetuximab Soravtansine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Mirvetuximab Soravtansine Production by Type (2021-2026) & (Units)
Table 49. World Mirvetuximab Soravtansine Production by Type (2027-2032) & (Units)
Table 50. World Mirvetuximab Soravtansine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Mirvetuximab Soravtansine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Mirvetuximab Soravtansine Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Mirvetuximab Soravtansine Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Mirvetuximab Soravtansine Production Value by Combination Medication, (USD Million), 2021 & 2025 & 2032
Table 55. World Mirvetuximab Soravtansine Production by Combination Medication (2021-2026) & (Units)
Table 56. World Mirvetuximab Soravtansine Production by Combination Medication (2027-2032) & (Units)
Table 57. World Mirvetuximab Soravtansine Production Value by Combination Medication (2021-2026) & (USD Million)
Table 58. World Mirvetuximab Soravtansine Production Value by Combination Medication (2027-2032) & (USD Million)
Table 59. World Mirvetuximab Soravtansine Average Price by Combination Medication (2021-2026) & (US$/Unit)
Table 60. World Mirvetuximab Soravtansine Average Price by Combination Medication (2027-2032) & (US$/Unit)
Table 61. World Mirvetuximab Soravtansine Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Mirvetuximab Soravtansine Production by Sales Channels (2021-2026) & (Units)
Table 63. World Mirvetuximab Soravtansine Production by Sales Channels (2027-2032) & (Units)
Table 64. World Mirvetuximab Soravtansine Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Mirvetuximab Soravtansine Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Mirvetuximab Soravtansine Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Mirvetuximab Soravtansine Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Mirvetuximab Soravtansine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Mirvetuximab Soravtansine Production by Application (2021-2026) & (Units)
Table 70. World Mirvetuximab Soravtansine Production by Application (2027-2032) & (Units)
Table 71. World Mirvetuximab Soravtansine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Mirvetuximab Soravtansine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Mirvetuximab Soravtansine Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Mirvetuximab Soravtansine Average Price by Application (2027-2032) & (US$/Unit)
Table 75. AbbVie Basic Information, Manufacturing Base and Competitors
Table 76. AbbVie Major Business
Table 77. AbbVie Mirvetuximab Soravtansine Product and Services
Table 78. AbbVie Mirvetuximab Soravtansine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. AbbVie Recent Developments/Updates
Table 80. AbbVie Competitive Strengths & Weaknesses
Table 81. Hangzhou Sino-American East China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 82. Hangzhou Sino-American East China Pharmaceutical Major Business
Table 83. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
Table 84. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
Table 86. Hangzhou Sino-American East China Pharmaceutical Competitive Strengths & Weaknesses
Table 87. Global Key Players of Mirvetuximab Soravtansine Upstream (Raw Materials)
Table 88. Global Mirvetuximab Soravtansine Typical Customers
Table 89. Mirvetuximab Soravtansine Typical Distributors
LIST OF FIGURES
Figure 1. Mirvetuximab Soravtansine Picture
Figure 2. World Mirvetuximab Soravtansine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mirvetuximab Soravtansine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 5. World Mirvetuximab Soravtansine Average Price (2021-2032) & (US$/Unit)
Figure 6. World Mirvetuximab Soravtansine Production Value Market Share by Region (2021-2032)
Figure 7. World Mirvetuximab Soravtansine Production Market Share by Region (2021-2032)
Figure 8. North America Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 9. Europe Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 10. China Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 11. Japan Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 12. India Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 13. Mirvetuximab Soravtansine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 16. World Mirvetuximab Soravtansine Consumption Market Share by Region (2021-2032)
Figure 17. United States Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 18. China Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 19. Europe Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 20. Japan Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 21. South Korea Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 22. ASEAN Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 23. India Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Mirvetuximab Soravtansine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mirvetuximab Soravtansine Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mirvetuximab Soravtansine Markets in 2025
Figure 27. United States VS China: Mirvetuximab Soravtansine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mirvetuximab Soravtansine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Mirvetuximab Soravtansine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Mirvetuximab Soravtansine Production Market Share 2025
Figure 31. China Based Manufacturers Mirvetuximab Soravtansine Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Market Share 2025
Figure 33. World Mirvetuximab Soravtansine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Mirvetuximab Soravtansine Production Value Market Share by Type in 2025
Figure 35. Lyophilized Powder for Injection
Figure 36. Injectable Solution
Figure 37. World Mirvetuximab Soravtansine Production Market Share by Type (2021-2032)
Figure 38. World Mirvetuximab Soravtansine Production Value Market Share by Type (2021-2032)
Figure 39. World Mirvetuximab Soravtansine Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Mirvetuximab Soravtansine Production Value by Combination Medication, (USD Million), 2021 & 2025 & 2032
Figure 41. World Mirvetuximab Soravtansine Production Value Market Share by Combination Medication in 2025
Figure 42. Mirvetuximab Soravtansine In Combination With Bevacizumab
Figure 43. Mirvetuximab Soravtansine In Combination With Carboplatin
Figure 44. World Mirvetuximab Soravtansine Production Market Share by Combination Medication (2021-2032)
Figure 45. World Mirvetuximab Soravtansine Production Value Market Share by Combination Medication (2021-2032)
Figure 46. World Mirvetuximab Soravtansine Average Price by Combination Medication (2021-2032) & (US$/Unit)
Figure 47. World Mirvetuximab Soravtansine Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Mirvetuximab Soravtansine Production Value Market Share by Sales Channels in 2025
Figure 49. Hospital
Figure 50. Retail
Figure 51. Online
Figure 52. World Mirvetuximab Soravtansine Production Market Share by Sales Channels (2021-2032)
Figure 53. World Mirvetuximab Soravtansine Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Mirvetuximab Soravtansine Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Mirvetuximab Soravtansine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Mirvetuximab Soravtansine Production Value Market Share by Application in 2025
Figure 57. FR?-Positive Recurrent Ovarian Cancer
Figure 58. Platinum-Resistant Epithelial Ovarian Cancer
Figure 59. FR?-Highly Expressed Advanced Solid Tumors
Figure 60. Others
Figure 61. World Mirvetuximab Soravtansine Production Market Share by Application (2021-2032)
Figure 62. World Mirvetuximab Soravtansine Production Value Market Share by Application (2021-2032)
Figure 63. World Mirvetuximab Soravtansine Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Mirvetuximab Soravtansine Industry Chain
Figure 65. Mirvetuximab Soravtansine Procurement Model
Figure 66. Mirvetuximab Soravtansine Sales Model
Figure 67. Mirvetuximab Soravtansine Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Mirvetuximab Soravtansine Picture
Figure 2. World Mirvetuximab Soravtansine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mirvetuximab Soravtansine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 5. World Mirvetuximab Soravtansine Average Price (2021-2032) & (US$/Unit)
Figure 6. World Mirvetuximab Soravtansine Production Value Market Share by Region (2021-2032)
Figure 7. World Mirvetuximab Soravtansine Production Market Share by Region (2021-2032)
Figure 8. North America Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 9. Europe Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 10. China Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 11. Japan Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 12. India Mirvetuximab Soravtansine Production (2021-2032) & (Units)
Figure 13. Mirvetuximab Soravtansine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 16. World Mirvetuximab Soravtansine Consumption Market Share by Region (2021-2032)
Figure 17. United States Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 18. China Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 19. Europe Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 20. Japan Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 21. South Korea Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 22. ASEAN Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 23. India Mirvetuximab Soravtansine Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Mirvetuximab Soravtansine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mirvetuximab Soravtansine Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mirvetuximab Soravtansine Markets in 2025
Figure 27. United States VS China: Mirvetuximab Soravtansine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mirvetuximab Soravtansine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Mirvetuximab Soravtansine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Mirvetuximab Soravtansine Production Market Share 2025
Figure 31. China Based Manufacturers Mirvetuximab Soravtansine Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Mirvetuximab Soravtansine Production Market Share 2025
Figure 33. World Mirvetuximab Soravtansine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Mirvetuximab Soravtansine Production Value Market Share by Type in 2025
Figure 35. Lyophilized Powder for Injection
Figure 36. Injectable Solution
Figure 37. World Mirvetuximab Soravtansine Production Market Share by Type (2021-2032)
Figure 38. World Mirvetuximab Soravtansine Production Value Market Share by Type (2021-2032)
Figure 39. World Mirvetuximab Soravtansine Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Mirvetuximab Soravtansine Production Value by Combination Medication, (USD Million), 2021 & 2025 & 2032
Figure 41. World Mirvetuximab Soravtansine Production Value Market Share by Combination Medication in 2025
Figure 42. Mirvetuximab Soravtansine In Combination With Bevacizumab
Figure 43. Mirvetuximab Soravtansine In Combination With Carboplatin
Figure 44. World Mirvetuximab Soravtansine Production Market Share by Combination Medication (2021-2032)
Figure 45. World Mirvetuximab Soravtansine Production Value Market Share by Combination Medication (2021-2032)
Figure 46. World Mirvetuximab Soravtansine Average Price by Combination Medication (2021-2032) & (US$/Unit)
Figure 47. World Mirvetuximab Soravtansine Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Mirvetuximab Soravtansine Production Value Market Share by Sales Channels in 2025
Figure 49. Hospital
Figure 50. Retail
Figure 51. Online
Figure 52. World Mirvetuximab Soravtansine Production Market Share by Sales Channels (2021-2032)
Figure 53. World Mirvetuximab Soravtansine Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Mirvetuximab Soravtansine Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Mirvetuximab Soravtansine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Mirvetuximab Soravtansine Production Value Market Share by Application in 2025
Figure 57. FR?-Positive Recurrent Ovarian Cancer
Figure 58. Platinum-Resistant Epithelial Ovarian Cancer
Figure 59. FR?-Highly Expressed Advanced Solid Tumors
Figure 60. Others
Figure 61. World Mirvetuximab Soravtansine Production Market Share by Application (2021-2032)
Figure 62. World Mirvetuximab Soravtansine Production Value Market Share by Application (2021-2032)
Figure 63. World Mirvetuximab Soravtansine Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Mirvetuximab Soravtansine Industry Chain
Figure 65. Mirvetuximab Soravtansine Procurement Model
Figure 66. Mirvetuximab Soravtansine Sales Model
Figure 67. Mirvetuximab Soravtansine Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
